News | July 22, 2024
dsm-firmenich to sell MEG-3 fish oil business to KD Pharma Group
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
dsm-firmenich decided to de-prioritize certain business segments, including the MEG-3 business
_256_384.jpg)
€ 6.6 million investment at Nantong site expands production capabilities for cell culture media
The expiry date of almost all strips is rubber stamped vanish in a matter of 3 to 4 months, making the remaining tablets waste for subsequent use before expire date
DCGI has also granted permission to manufacture and market FDF of Cefepime and Enmetazobactam as a dry powder injectable
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
New Bioprocessing Production Center in Daejeon to supply products to customers in Asia-Pacific for development and production of biologics
Venus Remedies' manufacturing unit, located in Baddi, Himachal Pradesh, has been recommended for supplying cephalosporin dry powder to UNICEF
The receipt of this permission paves way for the launch of Andexanet alfa powder for solution for infusion 200 mg (Andexxa) in India
Trastuzumab biosimilar is a humanized monoclonal antibody for treating metastatic breast cancer
Trastuzumab deruxtecan (Enhertu) is indicated for the treatment of adult patients with unresectable or metastatic HER2-positive breast cancer
Subscribe To Our Newsletter & Stay Updated
